{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:17:06Z","timestamp":1790378226399,"version":"4.1.0"},"reference-count":167,"publisher":"Elsevier","isbn-type":[{"value":"9780443417610","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["IDE\/2024\/000745"],"award-info":[{"award-number":["IDE\/2024\/000745"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","award":["PRDAS222516AGUI"],"award-info":[{"award-number":["PRDAS222516AGUI"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI23\/01576"],"award-info":[{"award-number":["PI23\/01576"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.ircmb.2026.02.004","type":"book-chapter","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:33:44Z","timestamp":1772022824000},"page":"139-171","source":"Crossref","is-referenced-by-count":2,"title":["Cytokine network in immunosuppression and tumor development in glioblastoma"],"prefix":"10.1016","author":[{"given":"Roc\u00edo","family":"Granda-D\u00edaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Mart\u00ednez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candelaria","family":"Aguilar-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Sordo-Bahamonde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.ircmb.2026.02.004_bib1","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1158\/2159-8290.CD-12-0502","article-title":"De-repression of PDGFRbeta transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patients","volume":"3","author":"Akhavan","year":"2013","journal-title":"Cancer Discovery"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119872","article-title":"IL22\/IL-22R pathway induces cell survival in human glioblastoma cells","volume":"10","author":"Akil","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.680021","article-title":"Targeting neuroinflammation in brain cancer: Uncovering mechanisms, pharmacological targets, and neuropharmaceutical developments","volume":"12","author":"Alghamri","year":"2021","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib4","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000038245","article-title":"Targeting inflammation in glioblastoma: An updated review from pathophysiology to novel therapeutic approaches","volume":"103","author":"Alorfi","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib5","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/s41388-017-0045-7","article-title":"Epidermal growth factor receptor and EGFRvIII in glioblastoma: Signaling pathways and targeted therapies","volume":"37","author":"An","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib6","doi-asserted-by":"crossref","first-page":"30215","DOI":"10.1074\/jbc.M112.370015","article-title":"Characterization and immunotherapeutic implications for a novel antibody targeting interleukin (IL)-13 receptor alpha2","volume":"287","author":"Balyasnikova","year":"2012","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.621831","article-title":"Current approaches for glioma gene therapy and virotherapy","volume":"14","author":"Banerjee","year":"2021","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrd2792","article-title":"The FGF family: Biology, pathophysiology and therapy","volume":"8","author":"Beenken","year":"2009","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib9","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1008824","article-title":"Interferon-gamma-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression","volume":"4","author":"Bellucci","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16010027","article-title":"Overexpression of growth differentiation factor 15 in glioblastoma stem cells promotes their radioresistance","volume":"16","author":"Bentaberry-Rosa","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101607","article-title":"Differential roles of type I interferon signaling in tumor versus host cells in experimental glioma models","volume":"28","author":"Blomberg","year":"2023","journal-title":"Translational Oncology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1215\/S1152851704001061","article-title":"The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis","volume":"7","author":"Brat","year":"2005","journal-title":"Neuro-Oncology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib13","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fimmu.2018.00847","article-title":"Interferon-Gamma at the crossroads of tumor immune surveillance or evasion","volume":"9","author":"Castro","year":"2018","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib14","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41419-023-06354-2","article-title":"The duality of CXCR3 in glioblastoma: Unveiling autocrine and paracrine mechanisms for novel therapeutic approaches","volume":"14","author":"Chan","year":"2023","journal-title":"Cell Death & Disease"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib15","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1158\/0008-5472.CAN-16-0144","article-title":"CCL2 Produced by the glioma microenvironment is essential for the recruitment of regulatory T cells and myeloid-derived suppressor cells","volume":"76","author":"Chang","year":"2016","journal-title":"Cancer Research"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib16","doi-asserted-by":"crossref","first-page":"53495","DOI":"10.18632\/oncotarget.18586","article-title":"TLR4 interaction with LPS in glioma CD133+ cancer stem cells induces cell proliferation, resistance to chemotherapy and evasion from cytotoxic T lymphocyte-induced cytolysis","volume":"8","author":"Che","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052509","article-title":"Friends with benefits: Chemokines, glioblastoma-associated microglia\/macrophages, and tumor microenvironment","volume":"23","author":"Codrici","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/neuonc\/nop009","article-title":"TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients","volume":"12","author":"Crane","year":"2010","journal-title":"Neuro-Oncology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib19","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3171\/jns.2002.96.2.0294","article-title":"Association of elevated glial expression of interleukin-1beta with improved survival in patients with glioblastomas multiforme","volume":"96","author":"Cuny","year":"2002","journal-title":"Journal of Neurosurgery"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib20","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1186\/s12864-023-09674-x","article-title":"Predictive value of CCL2 in the prognosis and immunotherapy response of glioblastoma multiforme","volume":"24","author":"Deng","year":"2023","journal-title":"BMC Genomics"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","article-title":"TGF-beta signaling in health, disease, and therapeutics","volume":"9","author":"Deng","year":"2024","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib22","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1038\/sj.onc.1202424","article-title":"Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma","volume":"18","author":"Desbaillets","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3892\/ijmm.2020.4801","article-title":"Prostaglandin E2 serves a dual role in regulating the migration of dendritic cells","volume":"47","author":"Diao","year":"2021","journal-title":"International Journal of Molecular Medicine"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fonc.2016.00256","article-title":"Immunotherapy of malignant tumors in the brain: How different from other sites?","volume":"6","author":"Dutoit","year":"2016","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21030888","article-title":"Integrin signaling in glioma pathogenesis: From biology to therapy","volume":"21","author":"Ellert-Miklaszewska","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25042316","article-title":"Epidermal growth factor receptor inhibitors in glioblastoma: Current status and future possibilities","volume":"25","author":"Ezzati","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib27","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/cbin.10353","article-title":"IL-1beta microenvironment promotes proliferation, migration, and invasion of human glioma cells","volume":"38","author":"Fathima Hurmath","year":"2014","journal-title":"Cell Biology International"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003750","article-title":"CRISPR-mediated TGFBR2 knockout renders human ovarian cancer tumor-infiltrating lymphocytes resistant to TGF-beta signaling","volume":"10","author":"Fix","year":"2022","journal-title":"Journal for ImmunoTherapy of Cancer"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib29","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1084\/jem.188.8.1413","article-title":"Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow","volume":"188","author":"Fong","year":"1998","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib30","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.18632\/oncotarget.3467","article-title":"Transforming growth factor-beta pathway activity in glioblastoma","volume":"6","author":"Frei","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib31","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrc3918","article-title":"Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma","volume":"15","author":"Furnari","year":"2015","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib32","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1471-4159.2008.05661.x","article-title":"Involvement of nuclear factor-kappa B in bcl-xL-induced interleukin 8 expression in glioblastoma","volume":"107","author":"Gabellini","year":"2008","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11060-009-0037-8","article-title":"Hepatocyte growth factor in cerebrospinal fluid is associated with mortality and recurrence of glioblastoma, and could be of prognostic value","volume":"97","author":"Garcia-Navarrete","year":"2010","journal-title":"Journal of Neuro-Oncology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061622","article-title":"Cellular plasticity and tumor microenvironment in gliomas: The struggle to hit a moving target","volume":"12","author":"Gargini","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1593\/neo.121536","article-title":"Regulation of HGF expression by DeltaEGFR-mediated c-Met activation in glioblastoma cells","volume":"15","author":"Garnett","year":"2013","journal-title":"Neoplasia (New York, N. Y.)"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00018-023-04788-7","article-title":"CCL21-CCR7 signaling promotes microglia\/macrophage recruitment and chemotherapy resistance in glioblastoma","volume":"80","author":"Geraldo","year":"2023","journal-title":"Cellular and Molecular Life Sciences: CMLS"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111511","article-title":"A molecular interactome of the glioblastoma perivascular niche reveals integrin binding sialoprotein as a mediator of tumor cell migration","volume":"41","author":"Ghochani","year":"2022","journal-title":"Cell Reports"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib38","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1158\/1541-7786.MCR-07-0088","article-title":"Modulation of bcl-xL in tumor cells regulates angiogenesis through CXCL8 expression","volume":"5","author":"Giorgini","year":"2007","journal-title":"Molecular Cancer Research: MCR"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib39","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/neuonc\/now136","article-title":"CXCL12 mediates glioblastoma resistance to radiotherapy in the subventricular zone","volume":"19","author":"Goffart","year":"2017","journal-title":"Neuro-Oncology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib40","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1158\/0008-5472.CAN-15-2058","article-title":"FGFR1 induces glioblastoma radioresistance through the PLCgamma\/Hif1alpha pathway","volume":"76","author":"Gouaze-Andersson","year":"2016","journal-title":"Cancer Research"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib41","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/cr.2008.76","article-title":"BCL-XL regulates TNF-alpha-mediated cell death independently of NF-kappaB, FLIP and IAPs","volume":"18","author":"Gozzelino","year":"2008","journal-title":"Cell Research"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21103704","article-title":"The role of selected chemokines and their receptors in the development of gliomas","volume":"21","author":"Groblewska","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib43","first-page":"458","article-title":"IL-6 Derived from therapy-induced senescence facilitates the glycolytic phenotype in glioblastoma cells","volume":"11","author":"Gu","year":"2021","journal-title":"American Journal of Cancer Research"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib44","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/cns.13749","article-title":"GDF15 expression in glioma is associated with malignant progression, immune microenvironment, and serves as a prognostic factor","volume":"28","author":"Guo","year":"2022","journal-title":"CNS Neuroscience & Therapeutics"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib45","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/cas.16128","article-title":"Upregulation of HLA-II related to LAG-3(+)CD4(+) T cell infiltration is associated with patient outcome in human glioblastoma","volume":"115","author":"Guo","year":"2024","journal-title":"Cancer Science"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib46","doi-asserted-by":"crossref","first-page":"80358","DOI":"10.18632\/oncotarget.18673","article-title":"Macrophage migration inhibitory factor promotes vasculogenic mimicry formation induced by hypoxia via CXCR4\/AKT\/EMT pathway in human glioblastoma cells","volume":"8","author":"Guo","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib47","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/cam4.20","article-title":"GM-CSF enhances tumor invasion by elevated MMP-2, -9, and -26 expression","volume":"2","author":"Gutschalk","year":"2013","journal-title":"Cancer Medicine"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib48","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1084\/jem.20111424","article-title":"Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth","volume":"209","author":"Hamerlik","year":"2012","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib49","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11060-017-2680-9","article-title":"Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor alpha1 and alpha2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme","volume":"136","author":"Han","year":"2018","journal-title":"Journal of Neuro-oncology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13619-022-00123-w","article-title":"Interferon-beta inhibits human glioma stem cell growth by modulating immune response and cell cycle related signaling pathways","volume":"11","author":"Han","year":"2022","journal-title":"Cell Regeneration"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib51","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1158\/1535-7163.MCT-13-0772","article-title":"Interferon-beta induces loss of spherogenicity and overcomes therapy resistance of glioblastoma stem cells","volume":"13","author":"Happold","year":"2014","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib52","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1054\/bjoc.2000.1445","article-title":"Hepatocyte growth factor\/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases","volume":"83","author":"Harvey","year":"2000","journal-title":"British Journal of Cancer"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib53","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.1002\/jcp.30289","article-title":"GDF-15: Diagnostic, prognostic, and therapeutic significance in glioblastoma multiforme","volume":"236","author":"Hasanpour Segherlou","year":"2021","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib54","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/2211-5463.13445","article-title":"G-CSF\/GM-CSF-induced hematopoietic dysregulation in the progression of solid tumors","volume":"12","author":"He","year":"2022","journal-title":"FEBS Open Bio"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib55","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022053","article-title":"Signaling receptors for TGF-beta family members","volume":"8","author":"Heldin","year":"2016","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib56","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12672-022-00567-1","article-title":"Natural killer cell immunotherapy in glioblastoma","volume":"13","author":"Hosseinalizadeh","year":"2022","journal-title":"Discover Oncology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib57","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.intimp.2011.03.015","article-title":"The profile of Th17 subset in glioma","volume":"11","author":"Hu","year":"2011","journal-title":"International Immunopharmacology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib58","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3892\/ol.2013.1518","article-title":"U87MG glioma cells overexpressing IL-17 acclerate early-stage growth in vivo and cause a higher level of CD31 mRNA expression in tumor tissues","volume":"6","author":"Hu","year":"2013","journal-title":"Oncology Letters"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib59","first-page":"3217","article-title":"Interleukin 10 is expressed in human gliomas in vivo and increases glioma cell proliferation and motility in vitro","volume":"17","author":"Huettner","year":"1997","journal-title":"Anticancer Research"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib60","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1101\/gad.1890510","article-title":"Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma","volume":"24","author":"Inda","year":"2010","journal-title":"Genes & Development"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib61","doi-asserted-by":"crossref","first-page":"7079","DOI":"10.1158\/0008-5472.CAN-13-1355","article-title":"Glioblastoma stem cells are regulated by interleukin-8 signaling in a tumoral perivascular niche","volume":"73","author":"Infanger","year":"2013","journal-title":"Cancer Research"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.395","article-title":"TGF-beta is an inducer of ZEB1-dependent mesenchymal transdifferentiation in glioblastoma that is associated with tumor invasion","volume":"5","author":"Joseph","year":"2014","journal-title":"Cell Death & Disease"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib63","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s13577-021-00619-8","article-title":"Macrophage\/microglia-derived IL-1beta induces glioblastoma growth via the STAT3\/NF-kappaB pathway","volume":"35","author":"Kai","year":"2022","journal-title":"Human Cell: Official Journal of Human Cell Research Society"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib64","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.nec.2009.08.011","article-title":"Interferon-gamma in brain tumor immunotherapy","volume":"21","author":"Kane","year":"2010","journal-title":"Neurosurgery Clinics of North America"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib65","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317699797","article-title":"Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin","volume":"39","author":"Kast","year":"2017","journal-title":"Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib66","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163446","article-title":"Macrophages and microglia in glioblastoma: Heterogeneity, plasticity, and therapy","volume":"133","author":"Khan","year":"2023","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215284","article-title":"Intrinsic interferon signaling regulates the cell death and mesenchymal phenotype of glioblastoma stem cells","volume":"13","author":"Khan","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib68","doi-asserted-by":"crossref","first-page":"9214","DOI":"10.1158\/0008-5472.CAN-07-1019","article-title":"Signal transducer and activator of transcription 1 regulates both cytotoxic and prosurvival functions in tumor cells","volume":"67","author":"Khodarev","year":"2007","journal-title":"Cancer Research"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib69","doi-asserted-by":"crossref","first-page":"802","DOI":"10.7150\/jca.104759","article-title":"Elevated serum IL-6 as a negative prognostic biomarker in glioblastoma: Integrating bioinformatics and clinical validation","volume":"16","author":"Kim","year":"2025","journal-title":"Journal of Cancer"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib70","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1158\/0008-5472.CAN-12-4124","article-title":"GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interleukin-4 receptor-alpha","volume":"73","author":"Kohanbash","year":"2013","journal-title":"Cancer Research"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib71","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3109\/08820139.2012.689591","article-title":"Myeloid-derived suppressor cells (MDSCs) in gliomas and glioma-development","volume":"41","author":"Kohanbash","year":"2012","journal-title":"Immunological Investigations"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11030406","article-title":"Alpha6-integrin regulates FGFR1 expression through the ZEB1\/YAP1 transcription complex in glioblastoma stem cells resulting in enhanced proliferation and stemness","volume":"11","author":"Kowalski-Chauvel","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179012","article-title":"Modulating glioma-mediated myeloid-derived suppressor cell development with sulforaphane","volume":"12","author":"Kumar","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib74","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s12032-024-02434-1","article-title":"The role of IL-17 in the pathogenesis and treatment of glioblastoma-an update on the state of the art and future perspectives","volume":"41","author":"Laszczych","year":"2024","journal-title":"Medical Oncology (Northwood, London, England)"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib75","doi-asserted-by":"crossref","first-page":"7306","DOI":"10.1158\/1078-0432.CCR-06-1727","article-title":"Profiling of CD4+, CD8+, and CD4+CD25+CD45RO+FoxP3+ T cells in patients with malignant glioma reveals differential expression of the immunologic transcriptome compared with T cells from healthy volunteers","volume":"12","author":"Learn","year":"2006","journal-title":"Clinical Cancer Research: an Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib76","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3389\/fimmu.2019.01261","article-title":"Type I interferon receptor on NK cells negatively regulates interferon-gamma production","volume":"10","author":"Lee","year":"2019","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib77","article-title":"Viral gene therapy for glioblastoma multiforme: A promising hope for the current dilemma","volume":"11","author":"Li","year":"2021","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib78","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1158\/1535-7163.MCT-08-0627","article-title":"Interactions between PTEN and the c-Met pathway in glioblastoma and implications for therapy","volume":"8","author":"Li","year":"2009","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib79","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1080\/10717544.2022.2075986","article-title":"Targeting interleukin-13 receptor alpha2 (IL-13Ralpha2) for glioblastoma therapy with surface functionalized nanocarriers","volume":"29","author":"Liang","year":"2022","journal-title":"Drug Delivery"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib80","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1007\/s12031-022-02083-x","article-title":"Exploring the correlation of abnormal CXCL9 expression with immune infiltration in glioma and patient prognosis based on TCGA and GTEx databases","volume":"72","author":"Liao","year":"2022","journal-title":"Journal of Molecular Neuroscience: MN"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib81","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13045-024-01544-7","article-title":"Understanding the immunosuppressive microenvironment of glioma: Mechanistic insights and clinical perspectives","volume":"17","author":"Lin","year":"2024","journal-title":"Journal of Hematology & Oncology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib82","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/s41419-018-1160-2","article-title":"Sensitization of glioblastoma cells to TRAIL-induced apoptosis by IAP- and Bcl-2 antagonism","volume":"9","author":"Lincoln","year":"2018","journal-title":"Cell Death & Disease"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib83","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41419-024-06784-6","article-title":"CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity","volume":"15","author":"Liu","year":"2024","journal-title":"Cell Death & Disease"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109718","article-title":"Pro-inflammatory and proliferative microglia drive progression of glioblastoma","volume":"36","author":"Liu","year":"2021","journal-title":"Cell Reports"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib85","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1007\/s00262-021-02872-0","article-title":"Regulatory T cells promote glioma cell stemness through TGF-beta-NF-kappaB-IL6-STAT3 signaling","volume":"70","author":"Liu","year":"2021","journal-title":"Cancer Immunology, Immunotherapy: CII"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib86","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1038\/s41467-018-05982-z","article-title":"PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastoma","volume":"9","author":"Liu","year":"2018","journal-title":"Nature Communications"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib87","doi-asserted-by":"crossref","first-page":"vdaa043","DOI":"10.1093\/noajnl\/vdaa043","article-title":"Interferon-beta exposure induces a fragile glioblastoma stem cell phenotype with a transcriptional profile of reduced migratory and MAPK pathway activity","volume":"2","author":"Lohmann","year":"2020","journal-title":"Neuro-Oncology Advances"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib88","first-page":"3729","article-title":"Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: Evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors","volume":"62","author":"Lokker","year":"2002","journal-title":"Cancer Research"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib89","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41568-018-0056-x","article-title":"Stem cell fate in cancer growth, progression and therapy resistance","volume":"18","author":"Lytle","year":"2018","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib90","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1158\/0008-5472.CAN-21-0035","article-title":"An oncolytic virus expressing IL15\/IL15Ralpha combined with off-the-shelf EGFR-CAR NK cells targets glioblastoma","volume":"81","author":"Ma","year":"2021","journal-title":"Cancer Research"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib91","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s13402-024-01007-8","article-title":"Cell death in glioblastoma and the central nervous system","volume":"48","author":"Malone","year":"2025","journal-title":"Cellular Oncology\u00a0(Dordr)"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib92","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.cmet.2013.09.013","article-title":"mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc","volume":"18","author":"Masui","year":"2013","journal-title":"Cell Metabolism"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib93","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.4049\/jimmunol.172.7.4275","article-title":"Smad3 is essential for TGF-beta 1 to suppress IL-2 production and TCR-induced proliferation, but not IL-2-induced proliferation","volume":"172","author":"Mckarns","year":"2004","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib94","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/bjp.2008.40","article-title":"A nitric oxide\/Ca(2+)\/calmodulin\/ERK1\/2 mitogen-activated protein kinase pathway is involved in the mitogenic effect of IL-1beta in human astrocytoma cells","volume":"153","author":"Meini","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib95","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0092-8674(03)00521-X","article-title":"Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes","volume":"114","author":"Micheau","year":"2003","journal-title":"Cell"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib96","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.it.2016.11.005","article-title":"T Cell exhaustion in glioblastoma: Intricacies of immune checkpoints","volume":"38","author":"Mirzaei","year":"2017","journal-title":"Trends in Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib97","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032111","article-title":"Natural killer cell-based immunotherapy against glioblastoma","volume":"24","author":"Morimoto","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib98","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF01328955","article-title":"Basic fibroblast growth factor and fibroblast growth factor receptor I are implicated in the growth of human astrocytomas","volume":"18","author":"Morrison","year":"1994","journal-title":"Journal of Neuro-oncology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib99","first-page":"197","article-title":"Engineering NK cells modified with an EGFRvIII-specific chimeric antigen receptor to overexpress CXCR4 improves immunotherapy of CXCL12\/SDF-1alpha-secreting Glioblastoma","volume":"38","author":"Muller","year":"2015","journal-title":"Journal of Immunotherapy (Hagerstown, Md.: 1997)"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib100","doi-asserted-by":"crossref","first-page":"7573","DOI":"10.1158\/0008-5472.CAN-05-0036","article-title":"IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide","volume":"65","author":"Natsume","year":"2005","journal-title":"Cancer Research"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib101","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ejcb.2016.05.002","article-title":"N-Cadherin and fibroblast growth factor receptors crosstalk in the control of developmental and cancer cell migrations","volume":"95","author":"Nguyen","year":"2016","journal-title":"European Journal of Cell Biology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib102","first-page":"9","article-title":"A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma","author":"O\u2019rourke","year":"2017","journal-title":"Science Translational Medicine"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.751183","article-title":"NK cell-based immunotherapy and therapeutic perspective in gliomas","volume":"11","author":"Pan","year":"2021","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib104","article-title":"Overcoming EGFR inhibitor resistance in glioblastoma by targeting co-amplified genes","volume":"120","author":"Pant","year":"2023","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.801230","article-title":"Ionizing radiation-induced GDF15 promotes angiogenesis in human glioblastoma models by promoting VEGFA expression through p-MAPK1\/SP1 signaling","volume":"12","author":"Park","year":"2022","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib106","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41698-024-00753-0","article-title":"CAR-T cell therapy for the treatment of adult high-grade gliomas","volume":"8","author":"Park","year":"2024","journal-title":"npj Precision Oncology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib107","doi-asserted-by":"crossref","first-page":"17040","DOI":"10.1038\/sigtrans.2017.40","article-title":"Targeting cellular pathways in glioblastoma multiforme","volume":"2","author":"Pearson","year":"2017","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib108","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ccr.2009.02.011","article-title":"TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma","volume":"15","author":"Penuelas","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib109","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.biocel.2008.01.008","article-title":"Activation of p38(MAPK) mediates the angiostatic effect of the chemokine receptor CXCR3-B","volume":"40","author":"Petrai","year":"2008","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib110","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/neuonc\/nos158","article-title":"Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype","volume":"14","author":"Piao","year":"2012","journal-title":"Neuro-Oncology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib111","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib112","first-page":"529","article-title":"Platelet-derived growth factor receptor-beta is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas","volume":"67","author":"Plate","year":"1992","journal-title":"Laboratory Investigation; a Journal of Technical Methods and Pathology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib113","doi-asserted-by":"crossref","first-page":"71673","DOI":"10.18632\/oncotarget.12317","article-title":"IL-10 secreted by M2 macrophage promoted tumorigenesis through interaction with JAK2 in glioma","volume":"7","author":"Qi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib114","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1158\/2326-6066.CIR-18-0020","article-title":"TLR2 promotes glioma immune evasion by downregulating MHC class II molecules in microglia","volume":"6","author":"Qian","year":"2018","journal-title":"Cancer Immunology Research"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib115","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1007\/s11033-010-0469-4","article-title":"IL-10 and TGF-beta2 are overexpressed in tumor spheres cultured from human gliomas","volume":"38","author":"Qiu","year":"2011","journal-title":"Molecular Biology Reports"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib116","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/s41467-022-28523-1","article-title":"T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10","volume":"13","author":"Ravi","year":"2022","journal-title":"Nature Communications"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib117","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/neuonc\/nor042","article-title":"Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma","volume":"13","author":"Raychaudhuri","year":"2011","journal-title":"Neuro-Oncology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib118","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fsurg.2016.00011","article-title":"Immune evasion strategies of glioblastoma","volume":"3","author":"Razavi","year":"2016","journal-title":"Frontiers in Surgery"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib119","doi-asserted-by":"crossref","first-page":"16513","DOI":"10.1074\/jbc.274.23.16513","article-title":"Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action","volume":"274","author":"Riley","year":"1999","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165798","article-title":"Functional roles of GDF15 in modulating microenvironment to promote carcinogenesis","volume":"1866","author":"Rochette","year":"2020","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib121","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126514","article-title":"Tumor vessels fuel the fire in glioblastoma","volume":"22","author":"Rosinska","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib122","doi-asserted-by":"crossref","first-page":"28220","DOI":"10.1074\/jbc.271.45.28220","article-title":"Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1","volume":"271","author":"Ryuto","year":"1996","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib123","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41698-024-00717-4","article-title":"Therapeutic approaches to modulate the immune microenvironment in gliomas","volume":"8","author":"Sarantopoulos","year":"2024","journal-title":"npj Precision Oncology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib124","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.immuni.2023.06.017","article-title":"Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression","volume":"56","author":"Sattiraju","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib125","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41590-019-0346-9","article-title":"Adaptive plasticity of IL-10(+) and IL-35(+) T(reg) cells cooperatively promotes tumor T cell exhaustion","volume":"20","author":"Sawant","year":"2019","journal-title":"Nature Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib126","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.4049\/jimmunol.1201018","article-title":"Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth","volume":"189","author":"Schlecker","year":"2012","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib127","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/neuonc\/nop076","article-title":"CX3CR1\/CX3CL1 axis negatively controls glioma cell invasion and is modulated by transforming growth factor-beta1","volume":"12","author":"Sciume","year":"2010","journal-title":"Neuro-Oncology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib128","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1158\/1535-7163.MCT-16-0465","article-title":"Biological role and therapeutic targeting of TGF-beta(3) in glioblastoma","volume":"16","author":"Seystahl","year":"2017","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib129","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.00441.2005","article-title":"CXCR3 chemokine receptor-induced chemotaxis in human airway epithelial cells: Role of p38 MAPK and PI3K signaling pathways","volume":"291","author":"Shahabuddin","year":"2006","journal-title":"American Journal of Physiology-Cell Physiology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib130","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142116","article-title":"Targeting the alphav integrin\/TGF-beta axis improves natural killer cell function against glioblastoma stem cells","volume":"131","author":"Shaim","year":"2021","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib131","doi-asserted-by":"crossref","first-page":"vdad009","DOI":"10.1093\/noajnl\/vdad009","article-title":"Tumor microenvironment in glioblastoma: Current and emerging concepts","volume":"5","author":"Sharma","year":"2023","journal-title":"Neuro-Oncology Advances"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174216","article-title":"Regulatory effects of IL-1beta in the interaction of GBM and tumor-associated monocyte through VCAM-1 and ICAM-1","volume":"905","author":"Shen","year":"2021","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib133","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00109-013-1019-z","article-title":"Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme","volume":"91","author":"Soda","year":"2013","journal-title":"Journal of Molecular Medicine\u00a0(Berl)"},{"issue":"8","key":"10.1016\/bs.ircmb.2026.02.004_bib134","first-page":"1962","article-title":"Overexpression of vascular endothelial growth factor isoforms drives oxygenation and growth but not progression to glioblastoma multiforme in a human model of gliomagenesis","volume":"63","author":"Sonoda","year":"2003","journal-title":"Cancer Research"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib135","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci14010089","article-title":"Interleukin-11\/IL-11 receptor promotes glioblastoma cell proliferation, epithelial-mesenchymal transition, and invasion","volume":"14","author":"Stuart","year":"2024","journal-title":"Brain Sciences"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib136","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3727\/096504014X13890370410285","article-title":"Inhibition of tumor angiogenesis by interferon-gamma by suppression of tumor-associated macrophage differentiation","volume":"21","author":"Sun","year":"2014","journal-title":"Oncology Research"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib137","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.562","article-title":"Interleukin-1beta promotes hypoxia-induced apoptosis of glioblastoma cells by inhibiting hypoxia-inducible factor-1 mediated adrenomedullin production","volume":"5","author":"Sun","year":"2014","journal-title":"Cell Death & Disease"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib138","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.3892\/ijo.2014.2620","article-title":"Interferon-beta inhibits glioma angiogenesis through downregulation of vascular endothelial growth factor and upregulation of interferon inducible protein 10","volume":"45","author":"Takano","year":"2014","journal-title":"International Journal of Oncology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib139","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1023\/A:1006476408190","article-title":"Inhibition of the glioblastoma cell cycle by type I IFNs occurs at both the G1 and S phases and correlates with the upregulation of p21(WAF1\/CIP1)","volume":"48","author":"Tanabe","year":"2000","journal-title":"Journal of Neuro-oncology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib140","doi-asserted-by":"crossref","first-page":"23302","DOI":"10.1002\/jcp.28898","article-title":"LncRNA-ATB promotes TGF-beta-induced glioma cells invasion through NF-kappaB and P38\/MAPK pathway","volume":"234","author":"Tang","year":"2019","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib141","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccr.2005.10.012","article-title":"TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance","volume":"8","author":"Thomas","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib142","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib143","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s10495-013-0886-7","article-title":"Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers","volume":"18","author":"Tiong","year":"2013","journal-title":"Apoptosis: an International Journal on Programmed Cell Death"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib144","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1158\/2159-8290.CD-11-0284","article-title":"Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors","volume":"2","author":"Vivanco","year":"2012","journal-title":"Cancer Discovery"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib145","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.canlet.2019.01.008","article-title":"IL-17 induces the proliferation and migration of glioma cells through the activation of PI3K\/Akt1\/NF-kappaB-p65","volume":"447","author":"Wang","year":"2019","journal-title":"Cancer Letters"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib146","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1007\/s10753-022-01779-x","article-title":"Hypoxia and TNF-alpha synergistically induce expression of IL-6 and IL-8 in human fibroblast-like synoviocytes via enhancing TAK1\/NF-kappaB\/HIF-1alpha signaling","volume":"46","author":"Wang","year":"2023","journal-title":"Inflammation"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib147","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11033-019-05146-2","article-title":"IFITM3\/STAT3 axis promotes glioma cells invasion and is modulated by TGF-beta","volume":"47","author":"Wang","year":"2020","journal-title":"Molecular Biology Reports"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib148","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4161\/cbt.19237","article-title":"Granulocyte-colony stimulating factor promotes proliferation, migration and invasion in glioma cells","volume":"13","author":"Wang","year":"2012","journal-title":"Cancer Biology & Therapy"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib149","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/labinvest.2011.128","article-title":"Tumor-secreted SDF-1 promotes glioma invasiveness and TAM tropism toward hypoxia in a murine astrocytoma model","volume":"92","author":"Wang","year":"2012","journal-title":"Laboratory Investigation; a Journal of Technical Methods and Pathology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib150","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.1246981","article-title":"Genetic screens in human cells using the CRISPR-Cas9 system","volume":"343","author":"Wang","year":"2014","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib151","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9050052","article-title":"Epidermal growth factor receptor cell proliferation signaling pathways","volume":"9","author":"Wee","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib152","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s40478-021-01163-0","article-title":"TNFalpha secreted by glioma associated macrophages promotes endothelial activation and resistance against anti-angiogenic therapy","volume":"9","author":"Wei","year":"2021","journal-title":"Acta Neuropathologica Communications"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib153","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S1470-2045(17)30517-X","article-title":"Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial","volume":"18","author":"Weller","year":"2017","journal-title":"The Lancet Oncology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib154","first-page":"4095","article-title":"The role of interleukin-6-STAT3 signalling in glioblastoma","volume":"16","author":"West","year":"2018","journal-title":"Oncology Letters"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib155","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1007\/s10637-020-00910-9","article-title":"Phase 1b\/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma","volume":"38","author":"Wick","year":"2020","journal-title":"Investigational New Drugs"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib156","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/s41416-021-01515-6","article-title":"IL-10 in glioma","volume":"125","author":"Widodo","year":"2021","journal-title":"British Journal of Cancer"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib157","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1158\/1078-0432.CCR-17-1846","article-title":"T-Cell exhaustion signatures vary with tumor type and are severe in glioblastoma","volume":"24","author":"Woroniecka","year":"2018","journal-title":"Clinical Cancer Research: an Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib158","article-title":"Macrophages in glioblastoma development and therapy: A double-edged sword","volume":"12","author":"Wu","year":"2022","journal-title":"Life (Chicago, Ill.: 1978) (Basel)"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib159","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3892\/or_00000690","article-title":"Constitutive NF-kappaB activity regulates the expression of VEGF and IL-8 and tumor angiogenesis of human glioblastoma","volume":"23","author":"Xie","year":"2010","journal-title":"Oncology Reports"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib160","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/417413","article-title":"VEGF promotes proliferation of human glioblastoma multiforme stem-like cells through VEGF receptor 2","volume":"2013","author":"Xu","year":"2013","journal-title":"TheScientificWorldJournal"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib161","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41419-022-04788-8","article-title":"TGF-beta induces GBM mesenchymal transition through upregulation of CLDN4 and nuclear translocation to activate TNF-alpha\/NF-kappaB signal pathway","volume":"13","author":"Yan","year":"2022","journal-title":"Cell Death & Disease"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib162","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3171\/jns.2004.100.2.0310","article-title":"Modulation of major histocompatibility complex class I molecules and major histocompatibility complex-bound immunogenic peptides induced by interferon-alpha and interferon-gamma treatment of human glioblastoma multiforme","volume":"100","author":"Yang","year":"2004","journal-title":"Journal of Neurosurgery"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib163","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092334","article-title":"Immunotherapy for glioblastoma: Current state, challenges, and future perspectives","volume":"12","author":"Yang","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib164","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/ncb2629","article-title":"ERK1\/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect","volume":"14","author":"Yang","year":"2012","journal-title":"Nature Cell Biology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib165","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/bph.12008","article-title":"Interleukins in glioblastoma pathophysiology: Implications for therapy","volume":"168","author":"Yeung","year":"2013","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153463","article-title":"Tumstatin attenuates the promotion effect of IL-17 secreted by Th17 cells on the stemness maintenance of glioma cells","volume":"223","author":"Yu","year":"2021","journal-title":"Pathology, Research and Practice"},{"key":"10.1016\/bs.ircmb.2026.02.004_bib167","doi-asserted-by":"crossref","first-page":"6650","DOI":"10.1158\/1078-0432.CCR-17-0120","article-title":"Infiltrating T cells increase IDO1 expression in glioblastoma and contribute to decreased patient survival","volume":"23","author":"Zhai","year":"2017","journal-title":"Clinical Cancer Research: an Official Journal of the American Association for Cancer Research"}],"container-title":["International Review of Cell and Molecular Biology","Cytokine-based immunotherapy - Part B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1937644826000067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1937644826000067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:37:47Z","timestamp":1783125467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1937644826000067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443417610"],"references-count":167,"URL":"https:\/\/doi.org\/10.1016\/bs.ircmb.2026.02.004","relation":{},"ISSN":["1937-6448"],"issn-type":[{"value":"1937-6448","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}